Page last updated: 2024-08-21

2-aminopurine and Pain

2-aminopurine has been researched along with Pain in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (37.50)18.2507
2000's8 (50.00)29.6817
2010's2 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amazonas, RB; de Oliveira, MFB; Gambero, S; Pott Junior, H1
Furue, M; Higa, K; Imafuku, S; Katayama, I; Nakayama, J; Takahara, M; Tani, M1
Wood, M1
Jubelt, B1
Ashton, R; Candaele, D; Decroix, J; Forszpaniak, C; Paulet, C; Shafran, SD; Tyring, SK; Wade, A1
Wassilew, S1
Wassilew, SW1
Boon, RJ; Griffin, DR2
Meiring, P; Pereles, L; Triscott, J1
Boon, RJ; Dworkin, RH; Griffin, DR; Phung, D1
Bernstein, DI; D'Ambrosio, JA; Raborn, GW; Rowe, NH; Spruance, SL; Thibodeau, EA1
Gnann, JW; Whitley, RJ1
Akhtar, M; DesJardin, J; Griffith, J; Koc, Y; Miller, KB; Schenkein, DP; Snydman, DR1
Belanger, R; Bezwoda, W; Boon, R; Ljungman, P; Saltzman, RL; Tyring, S1
Dworkin, RH; Griffin, DRJ; Johnson, RW; Nagasako, EM1

Reviews

6 review(s) available for 2-aminopurine and Pain

ArticleYear
Understanding pain in herpes zoster: an essential for optimizing treatment.
    The Journal of infectious diseases, 2002, Oct-15, Volume: 186 Suppl 1

    Topics: 2-Aminopurine; Acyclovir; Analgesics; Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Famciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Meta-Analysis as Topic; Pain; Pain Measurement; Proportional Hazards Models; Treatment Outcome; Valacyclovir; Valine

2002
[Varicella-zoster virus infections--2: Zoster pain -- therapy and prevention].
    MMW Fortschritte der Medizin, 2006, Volume: Spec no.1

    Topics: 2-Aminopurine; Acute Disease; Acyclovir; Administration, Oral; Adult; Age Factors; Analgesics, Non-Narcotic; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Antiviral Agents; Bromodeoxyuridine; Child; Drug Therapy, Combination; Famciclovir; Female; Herpes Zoster; Herpesvirus 3, Human; Herpesvirus Vaccines; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Prodrugs; Risk Factors; Sex Factors; Time Factors; Vaccination; Valacyclovir; Valine

2006
Efficacy of famciclovir in the treatment of herpes zoster: reduction of pain associated with zoster.
    Neurology, 1995, Volume: 45, Issue:12 Suppl 8

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Pain; Pain Measurement

1995
Famciclovir: efficacy in zoster and issues in the assessment of pain.
    Advances in experimental medicine and biology, 1996, Volume: 394

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Pain; Pain Measurement

1996
Therapeutic approaches to the management of herpes zoster.
    Advances in experimental medicine and biology, 1999, Volume: 458

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Pain; Prednisone; Prodrugs; Valacyclovir; Valine

1999
Acute pain in herpes zoster: the famciclovir database project.
    Pain, 2001, Volume: 94, Issue:1

    Topics: 2-Aminopurine; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Databases, Factual; Famciclovir; Female; Herpes Zoster; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pain; Risk Factors; Sex Factors

2001

Trials

8 trial(s) available for 2-aminopurine and Pain

ArticleYear
Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 72

    Topics: 2-Aminopurine; Acyclovir; Adult; Aged; Antiviral Agents; Famciclovir; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Pain; Pruritus; Treatment Outcome

2018
Valacyclovir and famciclovir therapy in herpes zoster.
    Current neurology and neuroscience reports, 2002, Volume: 2, Issue:6

    Topics: 2-Aminopurine; Acyclovir; Aged; Antiviral Agents; Double-Blind Method; Famciclovir; Gastrointestinal Diseases; Headache; Herpes Zoster; Humans; Middle Aged; Nausea; Neuralgia; Pain; Prospective Studies; Time Factors; Treatment Outcome; Valacyclovir; Valine

2002
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:4

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Double-Blind Method; Famciclovir; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Pain; Skin

2004
Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:1

    Topics: 2-Aminopurine; Acute Disease; Administration, Oral; Aged; Antiviral Agents; Bromodeoxyuridine; Chronic Disease; Double-Blind Method; Europe; Famciclovir; Female; Herpes Zoster; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome

2005
Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.
    The Journal of infectious diseases, 1998, Volume: 178 Suppl 1

    Topics: 2-Aminopurine; Acute Disease; Age Factors; Antiviral Agents; Double-Blind Method; Exanthema; Famciclovir; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Pain; Risk Factors; Time Factors

1998
Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:2

    Topics: 2-Aminopurine; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Double-Blind Method; Famciclovir; Female; Herpes Labialis; Humans; Male; Middle Aged; Pain; Time Factors; Ultraviolet Rays

1999
Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Chickenpox; Cytomegalovirus Infections; Famciclovir; Female; Graft vs Host Disease; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Male; Middle Aged; Pain; Retrospective Studies; Risk Factors; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Virus Activation

2000
A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
    Cancer investigation, 2001, Volume: 19, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Double-Blind Method; Famciclovir; Herpes Zoster; Humans; Immunocompromised Host; Male; Middle Aged; Pain; Skin Diseases

2001

Other Studies

2 other study(ies) available for 2-aminopurine and Pain

ArticleYear
One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study).
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:12

    Topics: 2-Aminopurine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cohort Studies; Famciclovir; Female; Follow-Up Studies; Herpes Zoster; Humans; Immunocompetence; Male; Middle Aged; Pain; Patient Compliance; Young Adult

2014
Dilemmas in care of the elderly.
    Canadian family physician Medecin de famille canadien, 1997, Volume: 43

    Topics: 2-Aminopurine; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Costs and Cost Analysis; Famciclovir; Female; Herpes Zoster; Humans; Middle Aged; Pain; Prodrugs; Time Factors

1997